Anti‐CD20 inhibits T cell‐mediated pathology and microgliosis in the rat brain-Reference-Cited by-同舟云学术

Anti‐CD20 inhibits T cell‐mediated pathology and microgliosis in the rat brain

Published:2014-09 Issue:9 Volume:1 Page:659-669
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Anthony Daniel C.¹,Dickens Alex M.¹,Seneca Nicholas²,Couch Yvonne¹,Campbell Sandra¹,Checa Begona³,Kersemans Veerle⁴,Warren Edward A.¹,Tredwell Matthew³,Sibson Nicola R.⁴,Gouverneur Veronique³,Leppert David²

Affiliation:

1. Department of Pharmacology University of Oxford Mansfield Road Oxford OX1 3QT United Kingdom

2. F. Hoffmann‐La Roche Ltd. Building 74/3W.306A, Grenzacherstrasse 183 CH‐4070 Basel Switzerland

3. Department of Chemistry University of Oxford Mansfield Road Oxford OX1 3TA United Kingdom

4. CR‐UK/MRC Gray Institute for Radiation Oncology and Biology University of Oxford Oxford OX3 7LJ United Kingdom

Funder

CRUK

F. Hoffmann-La Roche Ltd

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.94

Reference39 articles.

1. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?

2. Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis

3. Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis

4. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination

5. Identification of autoantibodies associated with myelin damage in multiple sclerosis

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B cell depletion with anti-CD20 promotes neuroprotection in a BAFF-dependent manner in mice and humans;Science Translational Medicine;2024-03-06

2. Modulating neuroinflammation through molecular, cellular and biomaterial‐based approaches to treat spinal cord injury;Bioengineering & Translational Medicine;2022-08-31

3. Relevance of Pathogenetic Mechanisms to Clinical Effectiveness of B-Cell-Depleting Monoclonal Antibodies in Multiple Sclerosis;Journal of Clinical Medicine;2022-07-23

4. Anti-CD20 Disrupts Meningeal B-Cell Aggregates in a Model of Secondary Progressive Multiple Sclerosis;Neurology - Neuroimmunology Neuroinflammation;2021-03-02

5. Targeting B Cells to Modify MS, NMOSD, and MOGAD;Neurology - Neuroimmunology Neuroinflammation;2020-12-16